Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Organisation Changes

20 Apr 2017 16:00

RNS Number : 9050C
Johnson Matthey PLC
20 April 2017
 

For release at 4.00 pm Thursday 20th April 2017

 

JM at 200 - Aligned for Growth

 

Johnson Matthey announces changes to its organisation

 

In 2017 Johnson Matthey celebrates its 200th year and in May we will launch a refreshed brand identity, "Inspiring science, enhancing life", to reflect our position as first and foremost a science led company which has a major positive impact on people's lives; making the world around us cleaner and healthier.

 

Johnson Matthey has made, and continues to make, significant progress in these areas but in order to perform in the current environment, we must increase our focus and build a more collaborative organisation. This will drive further synergies for customers and create value for shareholders. To achieve this, and to reinforce Johnson Matthey's brand identity, we will move to a group structure of four sectors aligned on the global priorities of cleaner air, the efficient use of natural resources and improved health:

· Clean Air

· Efficient Natural Resources

· Health

· New Markets

 

Clean Air is the new name for Emission Control Technologies Division. John Walker, Executive Director, will continue to lead this sector.

 

Efficient Natural Resources brings together Process Technologies Division and much of Precious Metal Products Division. There is an opportunity to deepen our presence in the chemicals, oil and gas, and industrial markets by enabling our customers to increase their efficient use of resources; making more out of less. Jane Toogood, currently Division Director of Precious Metal Products, will lead this sector.

 

Health will comprise much of our Fine Chemicals Division. Johnson Matthey is well positioned to build in this space through focusing on niche areas where we can differentiate using our expertise in complex chemistry. We will bring in a new leader from outside Johnson Matthey to head this sector. In the interim, Robert MacLeod, Chief Executive, will oversee this sector.

 

New Markets is the new name for our New Businesses Division. In addition to the current portfolio of businesses, it will incorporate the Medical Components business previously included in Precious Metal Products' Noble Metals business, and Fine Chemicals' Catalysis and Chiral Technologies business. Alan Nelson, currently Chief Technology Officer and Division Director of New Businesses, will lead this sector.

 

These changes are with immediate effect.

 

 

Enquiries:

Investor Relations

Simon McGough

Sarah Armstrong

 

Head of Investor Relations

Head of Investor Relations

 

020 7269 8235

020 7269 8426

Katharine Burrow

 

Media

Sally Jones

David Allchurch

Investor Relations Analyst

 

 

Director of Corporate Relations

Tulchan Communications

020 7269 8444

 

 

020 7269 8407

020 7353 4200

www.matthey.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALLEALSXEFF
Date   Source Headline
12th Feb 20257:00 amRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSBoard Changes
7th Feb 202510:15 amRNSDirector/PDMR Shareholding
6th Feb 20254:26 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSEstablishment of Investment Committee
27th Jan 20257:00 amRNSDelivering strategic objectives to drive value
23rd Jan 20254:47 pmRNSHolding(s) in Company
23rd Jan 20251:36 pmRNSDirector/PDMR Shareholding
22nd Jan 202510:13 amRNSHolding(s) in Company
15th Jan 20255:12 pmRNSHolding(s) in Company
8th Jan 20258:35 amRNSResponse to Letter from Standard Investments
7th Jan 20257:00 amRNSHolding(s) in Company
3rd Jan 20254:46 pmRNSHolding(s) in Company
31st Dec 20249:00 amRNSTotal Voting Rights
27th Dec 20248:07 amRNSHolding(s) in Company
23rd Dec 20244:21 pmRNSHolding(s) in Company
19th Dec 20243:10 pmRNSDirector/PDMR Shareholding
18th Dec 20243:17 pmRNSHolding(s) in Company
18th Dec 20243:08 pmRNSHolding(s) in Company
16th Dec 20244:36 pmRNSHolding(s) in Company
16th Dec 20244:06 pmRNSHolding(s) in Company
16th Dec 20241:13 pmRNSResponse to letter from Standard Investments
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20245:19 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTotal Voting Rights
9th Dec 20243:24 pmRNSHolding(s) in Company
9th Dec 20243:17 pmRNSHolding(s) in Company
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20243:33 pmRNSHolding(s) in Company
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20244:39 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20244:41 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20242:00 pmRNSTotal Voting Rights
29th Nov 20247:00 amRNSHolding(s) in Company
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20244:19 pmRNSDirector/PDMR Shareholding
28th Nov 20249:54 amRNSDirector/PDMR Shareholding
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20245:17 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSJohnson Matthey half year results
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20243:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.